Indemnification provisions are often among the most heavily negotiated terms in a clinical trial agreement, yet sponsors and sites frequently approach these clauses with very different perspectives on what constitutes an appropriate allocation of risk. In this session, attendees will hear from a sponsor-facing and a site-facing contracting professional, each explaining the business, legal, and operational considerations that drive their respective positions during negotiations. Through interactive discussion and real-world examples, the speakers will explore common points of disagreement, areas where compromise may be appropriate, and strategies for reaching mutually acceptable outcomes more efficiently. Attendees will better understand how each side evaluates indemnification risk and leave better equipped to negotiate provisions that are both practical and defensible.